Paul Chacko, MD
Clinical Cardiac Electrophysiology · Toledo, OHNPI 1932253200
Payments from drug & device makers
Across 361 payments — averaging $121.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Janssen Research & Development, LLC$16K
- Medtronic$7K
- Sanofi-aventis U.S. LLC$4K
- Boston Scientific$4K
- Biotronik Inc.$3K
- Biosense Webster, Inc.$3K
- plus $7K from 27 others
What the payments were for
- Speaking & faculty fees$3,61713%
- Travel & lodging$6,51523%
- Food & beverage$18,18464%
- Education$500%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Janssen Research & Development, LLC | 2 | $15,625 |
| Medtronic(2 entities) | 54 | $7,274 |
| Sanofi-aventis U.S. LLC | 5 | $3,927 |
| Boston Scientific | 69 | $3,666 |
| Biotronik Inc. | 31 | $3,480 |
| Biosense Webster, Inc. | 87 | $3,318 |
| Abbott | 37 | $2,232 |
| E.r. Squibb & Sons, L.L.C. | 12 | $605 |
| Philips North America LLC | 6 | $504 |
| Cardiofocus, Inc. | 5 | $502 |
| Atricure, Inc. | 3 | $455 |
| Johnson & Johnson | 6 | $329 |
| Kestra Medical Technology Services, Inc. | 4 | $296 |
| AstraZeneca | 6 | $288 |
| Cardiva Medical, Inc. | 3 | $226 |
| Anumana, Inc. | 1 | $157 |
| Impulse Dynamics (USA) Inc. | 3 | $151 |
| Penumbra, Inc. | 1 | $125 |
| Preventice Services, LLC | 4 | $124 |
| Amgen | 4 | $104 |
| Merit Medical Systems Inc | 1 | $83 |
| Haemonetics Corporation | 1 | $81 |
| Abiomed | 1 | $79 |
| Cordis US CORP. | 1 | $76 |
| Inari Medical, Inc. | 3 | $58 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 3 | $55 |
| Cook Medical LLC | 1 | $43 |
| Heartflow, Inc. | 1 | $39 |
| Novartis | 2 | $31 |
| Lilly USA, LLC | 1 | $22 |
| Smith+Nephew | 1 | $15 |
| Amarin Pharma, Inc. | 1 | $13 |
| Pfizer | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DiamondTemp$1,511
- EVERA MRI XT DR SURESCAN$1,072
- Carto 3$821
- INGEVITY$792
- Micra$755
- Selectra$750
- Solia$607
- HeartLight System$474
- Farapulse$374
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX$367
- Acticor 7 VR-T DX$330
- Arctic Front$233
- FARXIGA$225
- Carto 3 System$224
- CAMZYOS$218
- ECG-AI LEF$157
- Rhythmia Mapping System$141
- Ensite Cardiac Mapping System$139
- EnSite Precision Cardiac Mapping System$138
- Confirm Rx$130
How this compares
$43,991 in reported general payments places this provider in the 60th percentile of 159 clinical cardiac electrophysiology providers in Ohio.
See all clinical cardiac electrophysiology providers in Ohio →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 433 | $427,112 |
| XareltoRivaroxaban | 134 | $124,740 |
| EntrestoSacubitril/Valsartan | 20 | $30,477 |
| FarxigaDapagliflozin Propanediol | 27 | $26,763 |
| JardianceEmpagliflozin | 18 | $24,049 |
| Amiodarone Hcl | 296 | $6,427 |
| Metoprolol Succinate | 202 | $3,150 |
| Flecainide Acetate | 66 | $2,851 |
| Atorvastatin Calcium | 95 | $1,143 |
| SotalolSotalol Hcl | 71 | $1,122 |
| Midodrine Hcl | 13 | $764 |
| Doxycycline Monohydrate | 45 | $748 |
| Spironolactone | 86 | $722 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 41 | $618 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 25 | $575 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $12 | $427,112433 claims |
| Johnson & JohnsonXarelto | $329 | $124,740134 claims |
| NovartisEntresto | $31 | $30,47720 claims |
| AstraZenecaFarxiga | $288 | $26,76327 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 159 clinical cardiac electrophysiology providers in Ohio.
Other clinical cardiac electrophysiology in Toledo
- Jack LiToledo$157K
- Timothy PhelanToledo$107K
- Omar KahalyToledo$80K
- Muhammad AyubToledo$71K
- Walid SalibaCleveland$5.3M
- Anish AminColumbus$2.8M
- Bruce WilkoffCleveland$1.4M
- John HummelColumbus$1.4M
- Ayman HusseinCleveland$1.3M
- Gaurang GandhiCincinnati$990K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.